Calgarians celebrate $10 federal limit on non-sufficient funds fees, coming next year
Calgarians are celebrating a new federal regulation that will lower the fee charged when people don’t have enough money in ...
CochraneNow7d
Two runners ready for 10 marathons in 10 days across 10 provinces
Two Alberta runners are preparing for the challenge of a lifetime, 10 marathons in 10 days across 10 provinces, all to raise ...
Canada's pediatricians advised to support affirming gender-questioning six-year-olds
The Canadian paper advises pediatricians to offer parents of gender-questioning children advice on social transitions and the ...
CHEK News9h
‘Worth the wait’: Nanaimo man wins medal at Special Olympics in Italy for skiing
A Nanaimo man says he’s proud to have represented the Island and Canada after winning a medal for skiing at the recent ...
Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome
Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc.
Parents, students join Foothills School Division support staff picket line
Support staff with the Foothills School Division have been on strike since Feb. 24 and while workers hit the picket lines, many of the children they support aren’t able to attend school. Jamie ...
Marvel Biosciences Corp.: Marvel Announces First of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide
Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel") ...
Community events in San Diego County: From Desert BioBlitz to Garden Walking Tour
Sneak peek at upcoming San Diego community events street fairs, festivals, concerts, performances, art shows, community ...
Marvel Biosciences Corp.: Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome
Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel") ...
Marvel Announces First of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide
Detailed price information for Marvel Biosciences Corp (MRVL-X) from The Globe and Mail including charting and trades.